Gülay Koçak

6PUBLICATIONS
12CO-AUTHORS
PharmacogenomicsClinical chemistry (incl. diagnostics)Predictive and prognostic markersPhotochemistryCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 22, 2026
Polycythemia due to SGLT-2 inhibitors: who is at risk?

|Sep 01, 2025
Use of Procalcitonin for Detection of Bacterial Infection in Patients With Chronic Kidney Disease: A Retrospective Cohort Study.

Onder Sabahat, Aylia Yesilova, Namigar Turgut

|Apr 26, 2024
Evaluation of contrast induced nephropathy related risk factors and long-term results.

Alper Koyuncuoğlu, Münevver Gül Avşar, Ahmet Tarhan

|Jul 01, 2022
The evaluation of urinary calprotectin levels for prediction of acute cisplatin-induced nephrotoxicity.

Gülay Koçak, Gamze Bilik, Aylia Yeşilova

|Aug 14, 2021
Evaluation of acute and chronic nephrotoxicity in patients received cisplatin-based chemotherapy: has anything changed over time?

Şule Çelik Kamacı, Gülay Koçak, Aylia Yeşilova

|Oct 02, 2020
Kimura Disease Associated with Minimal Change Disease

Rafet Eren, Enes Cömert, İlknur Mansuroğlu

Pageof 1

Frequent Collaborators

1 joint publications

Rafet Eren

1 joint publications

Enes Cömert

1 joint publications

İlknur Mansuroğlu

1 joint publications

Esma Evrim Doğan